Policy & Regulation
Applied BioMath collaborates with BYOMass Inc
18 October 2021 -

Applied BioMath, a US-based company that deals with implementing systems pharmacology and mechanistic modelling, simulation, and analysis to de-risk drug research and development, announced on Friday that it has collaborated with US-based BYOMass Inc., a preclinical pharmaceutical company.

The collaboration is aimed at systems pharmacology modelling in chronic diseases.

Margaret Jackson, D.Phil., BYOMass founder and CEO, said, 'We chose Applied BioMath given their proven track record of helping companies identify ideal therapeutic properties and platforms. We hope that this collaboration will help us identify the properties of a lead candidate as efficiently as possible and aid in the design of future studies.'



Related Headlines